Implantica AG (FRA:8IM1) Debt-to-Equity: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8IM1 Implantica AG FRA:8IM1
34 GF Score
Price €5.36
View Full Analysis

What is Implantica AG Debt-to-Equity?

Implantica AG FRA:8IM1 -4.46% 34 Debt-to-Equity is 0.00 as of . 20. GuruFocus rates FRA:8IM1 with a GF Score™ of 34/100. Among 696 Medical Devices & Instruments companies, Implantica AG ranks worse than 143678.02% on this metric.

Implantica AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was €0.00 Mil. Implantica AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was €0.00 Mil. Implantica AG's Total Stockholders Equity for the quarter that ended in . 20 was €0.00 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Implantica AG's Debt-to-Equity or its related term are showing as below:

FRA:8IM1's Debt-to-Equity is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.24
* Ranked among companies with meaningful Debt-to-Equity only.

Implantica AG  (FRA:8IM1) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Implantica AG Debt-to-Equity Related Terms

Implantica AG Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Implantica AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Implantica AG Debt-to-Equity Chart

Implantica AG Annual Data
Trend
Debt-to-Equity

Implantica AG Semi-Annual Data
Debt-to-Equity

FRA:8IM1 vs : Debt-to-Equity Comparison

For the Medical Devices subindustry, Implantica AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Implantica AG Debt-to-Equity vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Implantica AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Implantica AG's Debt-to-Equity falls into.


FRA:8IM1
34GF Score
Implantica AG FRA:8IM1
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Implantica AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Implantica AG's Debt to Equity Ratio for the fiscal year that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) / N/A
=N/A

Implantica AG's Debt to Equity Ratio for the quarter that ended in . 20 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=( + ) /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
Implantica AG (FRA:8IM1) has a Debt-to-Equity of 0.00 as of . 20. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Implantica AG and its competitors. According to the industry distribution chart, Implantica AG ranks #999999 out of 696 companies in the Medical Devices & Instruments industry.
Is Implantica AG's Debt-to-Equity too high?
Implantica AG's current Debt-to-Equity is 0.00. Based on the distribution chart, Implantica AG ranks #999999 out of 696 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Implantica AG has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Implantica AG's Debt-to-Equity compare to ?
According to the Medical Devices & Instruments industry distribution chart, Implantica AG ranks #999999 out of 696 companies for Debt-to-Equity. This places Implantica AG in the lower half of its industry. The industry median Debt-to-Equity is 0.24. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 696 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Implantica AG and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Implantica AG's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Implantica AG stock overvalued right now?
Implantica AG (FRA:8IM1) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. Implantica AG's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Implantica AG (FRA:8IM1), the current Debt-to-Equity is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Implantica AG Business Description

Comparable Companies
Other Exchanges IMP A SDB:Sweden
Address Aeulestrasse 15, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected product pipeline based partly on its two platform technologies: an eHealth platform designed to monitor a broad range of health parameters, control treatment from inside the body, and communicate with the caregiver at a distance, and a wireless energising platform designed to power remote-controlled implants wirelessly through intact skin.
34GF Score

Get the complete analysis for FRA:8IM1

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.36
Price